Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Its new system marks a groundbreaking advance in the field of testing for bloodstream infections.
Investors were encouraged by a recent award the company received in the effort to diagnose and treat sepsis more rapidly.
AXDX earnings call for the period ending March 31, 2020.
AXDX earnings call for the period ending December 31, 2019.
AXDX earnings call for the period ending September 30, 2019.
AXDX earnings call for the period ending June 30, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.